4 Amendments of Eleni THEOCHAROUS related to 2011/0401(COD)
Amendment 58 #
Proposal for a regulation
Article 21 – paragraph 2 – subparagraph 3 a (new)
Article 21 – paragraph 2 – subparagraph 3 a (new)
Coordination policies will, in addition, work in line with migration, asylum and developmental policies, in order to avoid a "brain drain" from developing countries.
Amendment 74 #
Proposal for a regulation
Annex I – part III – point 1.1 – paragraph 6
Annex I – part III – point 1.1 – paragraph 6
Infectious diseases (e.g. HIV/AIDS, tuberculosis and malaria, malaria and poverty-related and neglected diseases), are a global concern, accounting for 41% of the 1.5 billion disability adjusted life years worldwide, with 8% of these in Europe. Emerging epidemics and the threat of increasing anti-microbial resistance must also be prepared for.
Amendment 79 #
Proposal for a regulation
Annex I – part III – point 1.2 – paragraph 3
Annex I – part III – point 1.2 – paragraph 3
Similarly, the complexity of the challenge and the interdependency of its components demand a European level response. Many approaches, tools and technologies have applicability across many of the research and innovation areas of this challenge and are best supported at Union level. These include the development of long term cohorts and the conduct of clinical trials, the clinical use of ‘-omics’ or the development of ICT and their applications in healthcare practice, notably e-health. The requirements of specific populations are also best addressed in an integrated manner, for example in the development of stratified and/or personalised medicine, in the diagnosis, prevention and treatment of rare diseases, and in providing assisted and independent living solutions.
Amendment 80 #
Proposal for a regulation
Annex I – part III – point 1.2 – paragraph 4
Annex I – part III – point 1.2 – paragraph 4
To maximise the impact of Union level actions and create long-term benefits to its objectives, support will be provided to the full spectrum of research and innovation activities. From basic research through translation of knowledge to large trials and demonstration actions, mobilising private investment; to public and pre-commercial procurement for new products, services, scalable solutions, which are when necessary, interoperable and supported by defined standards and/or common guidelines. This co-ordinated, European effort will contribute to the ongoing development of the ERA. It will also interface, as and when appropriate, with activities developed in the context of the Health for Growth Programme and the European Innovation Partnership on Active and Health Ageing.